Endpoints for validation of tumor markers for recurrence risk: Recurrence-free interval (RFI), disease-free survival (DFS), overall survival (OS), and colon-cancer specific survival (CCSS) in CALGB 9581
- Citation:
- Eur J Cancer vol 47 (Suppl 1) S172
- Meeting Instance:
- ECCO 2011
- Year:
- 2011
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 989
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- N. N. Mahmoud M. Lopatin M. Lee K. Clark-Langone D. Niedzwiecki A. P. Venook
- Networks:
- Study
- Alliance-9581
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- Keywords: